 Now rapamycin is being studied to see if it can slow down age-related diseases in humans. Stories coming up in the next half hour of Morning Edition here on Little Rock Public Radio. It's 720. Today's Here's to Your Health segment with Dr. T. Glenn Pate is brought to you by the University of Arkansas for Medical Sciences.